Validation of New Virtual Reality Treatment for Children With Lazy Eye Using the Vedea Amblyopia Therapy (VAT) (VAT)
'Validation and Development of New Dichoptic VR-gaming Method to Treat Childhood Amblyopia; Vedea Amblyopia Therapy (VAT)
Sponsor: Elisabeth-TweeSteden Ziekenhuis
This NA trial investigates Amblyopia and Amblyopia Strabismic and is currently ongoing. Elisabeth-TweeSteden Ziekenhuis leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting NA
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Recruiting NA
-
Apr 2024 — Jul 2024 [monthly]
Recruiting NA
-
Jun 2023 — Apr 2024 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Mar 2023 — Jun 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Dec 2022 — Mar 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Elisabeth-TweeSteden Ziekenhuis
- Health Holland
- Jeroen Bosch Ziekenhuis
- Oogziekenhuis Rotterdam
- Rotterdams Oogheelkundig Instituut
- Vedea Healthware BV
For direct contact, visit the study record on ClinicalTrials.gov .